Article Information
vol. 5 no. 3
Published By
Online ISSN
History
- Received May 8, 2019
- Accepted June 11, 2019
- Published online August 5, 2019.
Copyright & Usage
Copyright ©ERS 2019 This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
Author Information
- Vijay Kunadian1,2⇑,
- Nina Wilson3,
- Deborah D. Stocken3,4,
- Hani Ali1,2,
- Elaine McColl3,
- Graham Burns5,
- Nicola Howe6,
- Andrew Fisher1,2 and
- Anthony De Soyza1,2
- on behalf of the APPLE COPD-ICON2 trial investigators
- Vijay Kunadian, Institute of Cellular Medicine, Faculty of Medical Sciences, Newcastle University, 4th Floor, William Leech Building, Newcastle-upon-Tyne, NE2 4HH, UK. E-mail: vijay.kunadian{at}newcastle.ac.uk
- 1Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK
- 2Cardiothoracic Centre, Freeman Hospital, Newcastle upon Tyne NHS Foundation Trust, Newcastle upon Tyne, UK
- 3Institute of Health and Society, Newcastle University, Newcastle upon Tyne, UK
- 4Leeds Institute of Clinical Trial Research, University of Leeds, Leeds, UK
- 5Royal Victoria Infirmary, Newcastle upon Tyne NHS Foundation Trust, Newcastle upon Tyne, UK
- 6Newcastle Clinical Trials Unit, Newcastle upon Tyne NHS Foundation Trust, Newcastle upon Tyne, UK
Funding
AstraZeneca
ISSBRIL0303
Article usage
Altmetrics
Vol 5 Issue 3
Table of Contents
Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: a randomised controlled proof-of-concept trial
